Provides global market access and HEOR consultancy to life-sciences clients, guiding market entry and reimbursement strategies for pharmaceuticals, medical devices and diagnostics. Specialist expertise in advanced gene and cell therapies for rare, life‑limiting disorders to achieve optimal access outcomes for novel products.